A 2026 study of 192 Parkinson’s disease patients found that those with thinking problems had significantly higher homocysteine levels and lower folate and vitamin B₁₂ levels compared to those with normal cognition. According to Gram Research analysis, this suggests B vitamin deficiency may be connected to cognitive decline in Parkinson’s disease, though supplementation studies are needed to confirm whether increasing these vitamins actually prevents or slows thinking problems.
Researchers studied 192 people with early Parkinson’s disease to understand why some develop thinking problems while others don’t. They found that people with Parkinson’s who had memory and thinking difficulties had higher levels of a substance called homocysteine and lower levels of folate and vitamin B₁₂ in their blood. According to Gram Research analysis, these vitamin deficiencies appear connected to cognitive decline in Parkinson’s patients. The findings suggest that B vitamin supplementation might help protect thinking skills, though more research is needed to confirm whether taking these vitamins actually prevents or slows cognitive problems in Parkinson’s disease.
Key Statistics
A 2026 study of 192 levodopa-naïve Parkinson’s disease patients found that those with mild cognitive impairment had significantly higher serum homocysteine levels and significantly lower folate and vitamin B₁₂ levels compared to Parkinson’s patients with normal cognition (p < 0.01).
Among 89 Parkinson’s disease patients with mild cognitive impairment, cognitive test scores were negatively correlated with homocysteine levels and positively correlated with folate and vitamin B₁₂ levels, suggesting a protective association between B vitamins and thinking ability.
In a 2026 analysis of 192 early Parkinson’s disease patients, those with elevated homocysteine levels scored significantly lower on cognitive assessments compared to those with normal homocysteine levels, indicating a potential link between this protein and thinking decline.
The Quick Take
- What they studied: Whether low levels of B vitamins (folate and B₁₂) and high levels of a protein called homocysteine are connected to thinking and memory problems in people with early Parkinson’s disease
- Who participated: 192 people with early Parkinson’s disease who had never taken levodopa medication, split into two groups based on thinking ability, plus 89 healthy people as a comparison group
- Key finding: People with Parkinson’s who had thinking problems showed significantly higher homocysteine levels and significantly lower folate and B₁₂ levels compared to those with normal thinking and healthy controls
- What it means for you: If you have Parkinson’s disease, maintaining healthy B vitamin levels might help protect your thinking and memory skills, though doctors should confirm this before recommending supplements
The Research Details
This was a retrospective study, meaning researchers looked back at medical records and test results from 192 people with early Parkinson’s disease who had never taken levodopa (a common Parkinson’s medication). They divided these patients into two groups based on cognitive testing scores: 89 people with mild thinking problems and 103 with normal thinking. They also included 89 healthy people as a comparison group. All three groups had their blood tested for homocysteine, folate, and vitamin B₁₂ levels, and their thinking abilities were measured using a standard cognitive test called the Montreal Cognitive Assessment (MoCA).
The researchers compared the blood test results and thinking scores across all three groups to see if there were patterns. They used statistical analysis to determine whether the differences they found were meaningful and not due to chance. They also looked at whether the blood vitamin levels correlated with thinking test scores within the Parkinson’s groups.
This research approach is important because it examines early Parkinson’s disease before patients start medication, which could affect these vitamin levels. By comparing Parkinson’s patients to healthy controls, researchers could identify whether the vitamin changes are specific to Parkinson’s disease. Understanding these connections might lead to preventive strategies to protect thinking skills in Parkinson’s patients.
This study has several strengths: it included a reasonable sample size (192 Parkinson’s patients), used standardized cognitive testing, and included a healthy control group for comparison. However, as a retrospective study, it can only show associations, not prove that low vitamins cause thinking problems. The study was conducted at a single time point, so it doesn’t show whether these vitamin levels change over time or whether supplementation would help.
What the Results Show
Compared to Parkinson’s patients with normal thinking ability, those with mild cognitive impairment scored significantly lower on multiple thinking tests, including tests of visual-spatial skills, executive function (planning and decision-making), attention, math ability, abstract thinking, and memory recall.
Blood test results showed a clear pattern: Parkinson’s patients with thinking problems had significantly higher homocysteine levels and significantly lower folate and vitamin B₁₂ levels compared to both Parkinson’s patients with normal thinking and healthy control subjects. These differences were statistically significant (p < 0.01), meaning they were very unlikely to occur by chance.
When researchers looked only at Parkinson’s patients, those with high homocysteine levels had lower cognitive test scores than those with normal homocysteine levels. Statistical analysis showed that cognitive scores were negatively correlated with homocysteine (meaning higher homocysteine was associated with lower thinking scores) and positively correlated with folate and B₁₂ levels (meaning higher vitamin levels were associated with better thinking scores).
The study found that the vitamin and homocysteine changes were specific to Parkinson’s patients with cognitive impairment—healthy controls had normal levels of all three markers. This suggests these changes are related to Parkinson’s disease progression rather than general aging. The pattern was consistent across multiple thinking domains, suggesting a broad effect on cognition rather than affecting just one type of thinking skill.
These findings align with previous research showing that homocysteine elevation and B vitamin deficiency are associated with cognitive decline in other neurological conditions. However, this is one of the first studies to specifically examine this relationship in early Parkinson’s disease before medication treatment begins. The results support the biological plausibility that B vitamins may play a protective role in Parkinson’s-related cognitive decline.
This was a retrospective study looking at data from one point in time, so it cannot prove that low B vitamins cause thinking problems—only that they’re associated. The study doesn’t tell us whether supplementing with B vitamins would actually improve thinking or prevent decline. The sample came from a single medical center, which may not represent all Parkinson’s patients. The study didn’t account for diet, which affects B vitamin levels, or other factors that might influence both vitamin levels and thinking ability.
The Bottom Line
People with Parkinson’s disease should have their B vitamin levels checked as part of routine care (moderate confidence). If levels are low, supplementation with folate and B₁₂ may be beneficial, though this needs confirmation in future studies (low to moderate confidence). This should be discussed with a neurologist or healthcare provider rather than self-treating.
This research is most relevant to people with early Parkinson’s disease, especially those noticing thinking or memory changes. It’s also important for neurologists and Parkinson’s specialists who manage cognitive symptoms. Healthy people should not assume they need B vitamin supplementation based on this study.
If B vitamin supplementation does help, benefits would likely take weeks to months to appear, as cognitive changes in Parkinson’s typically develop gradually. This is not a quick fix but rather a potential long-term strategy to support brain health.
Frequently Asked Questions
Does low B12 cause cognitive problems in Parkinson’s disease?
A 2026 study of 192 Parkinson’s patients found that those with thinking problems had significantly lower B₁₂ and folate levels, suggesting an association. However, this study cannot prove causation—only that the deficiency and cognitive decline occur together. More research is needed.
Should I take B vitamin supplements if I have Parkinson’s disease?
Discuss with your neurologist about checking your B₁₂ and folate levels first. If levels are low, supplementation may be beneficial based on this research, but individual recommendations depend on your specific situation and other health factors.
Can B vitamins prevent thinking problems in Parkinson’s?
This study shows an association between low B vitamins and cognitive decline in Parkinson’s, but it doesn’t prove supplementation prevents problems. Intervention studies are needed to confirm whether taking these vitamins actually protects thinking ability.
What B vitamins are important for Parkinson’s brain health?
This research specifically identified folate and vitamin B₁₂ as potentially important for cognitive function in Parkinson’s disease. Both are found in foods like leafy greens, eggs, fish, and legumes, or can be taken as supplements under medical supervision.
How quickly would B vitamin supplements help my thinking?
If supplementation helps, benefits would likely take weeks to months to appear, as cognitive changes in Parkinson’s develop gradually. This isn’t a quick fix but a potential long-term strategy to support brain health alongside other treatments.
Want to Apply This Research?
- Track B vitamin intake (folate and B₁₂ sources from food or supplements) and monthly cognitive self-assessments using simple memory or attention tests, correlating changes with vitamin intake patterns
- Add B vitamin-rich foods to daily meals (leafy greens, eggs, fish, legumes) and set reminders for B₁₂ supplementation if recommended by your doctor; log these in the app to monitor consistency
- Quarterly check-ins with cognitive function scores and semi-annual blood work to track homocysteine, folate, and B₁₂ levels, with app notifications to schedule appointments and log results
This research shows an association between B vitamin levels and cognitive function in Parkinson’s disease but does not prove that supplementation prevents or treats cognitive decline. Anyone with Parkinson’s disease considering B vitamin supplementation should consult with their neurologist or healthcare provider before starting supplements, as individual needs vary and supplements can interact with medications. This information is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.